The automatic immunohistochemical staining instrument market size has grown strongly in recent years. It will grow from $1.3 billion in 2025 to $1.4 billion in 2026 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to rising cancer diagnostic testing volumes, expansion of pathology laboratory infrastructure, increased reliance on immunohistochemistry in disease diagnosis, growing availability of automated laboratory instruments, rising demand for reproducible diagnostic results.
The automatic immunohistochemical staining instrument market size is expected to see strong growth in the next few years. It will grow to $1.83 billion in 2030 at a compound annual growth rate (CAGR) of 7%. The growth in the forecast period can be attributed to increasing adoption of precision oncology diagnostics, growing investments in digital pathology platforms, rising demand for laboratory automation, expansion of companion diagnostics development, increasing focus on personalized medicine approaches. Major trends in the forecast period include increasing adoption of fully automated ihc staining systems, rising demand for high-throughput diagnostic workflows, growing integration of digital pathology compatibility, expansion of standardized and reproducible staining protocols, enhanced focus on workflow efficiency in laboratories.
The increasing prevalence of chronic diseases is expected to drive the growth of the automatic immunohistochemical staining instrument market. Chronic diseases refer to long-term medical conditions that typically progress gradually and require continuous management. These include diabetes, heart disease, hypertension, arthritis, chronic respiratory diseases, cancer, and obesity. The rise in chronic diseases is linked to lifestyle changes, poor diet, and insufficient physical activity, all contributing to long-term health complications. Automatic immunohistochemical staining instruments improve diagnostic capabilities by offering precise and efficient tissue analysis, making them crucial for detecting chronic diseases. These instruments reduce manual labor with fast, automated staining processes, improving diagnostic accuracy and enabling earlier disease detection. For example, in June 2024, the National Health Service (NHS) in the UK reported that 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, an 18% increase from 3,065,825 cases in 2022. Therefore, the growing prevalence of chronic diseases is driving the expansion of the automatic immunohistochemical staining instrument market.
Companies in the automatic immunohistochemical staining instrument market are focusing on developing innovative solutions, such as antibody alternative reagents, to enhance the accuracy, efficiency, and versatility of tissue analysis while reducing costs and improving reproducibility. An antibody alternative reagent is a non-antibody molecule, such as an aptamer, affirmer, or antibody mimetic, that can specifically bind to target antigens and be used instead of traditional antibodies in research, diagnostic, or therapeutic applications. For example, in March 2023, Aptamer Group plc, a U.K.-based biotechnology company, launched Optimer-Fc, a new reagent solution for automated immunohistochemistry (IHC) workflows. Optimer-Fc offers an innovative antibody alternative for immunohistochemistry, expanding target detection capabilities and enhancing assay selectivity. It integrates seamlessly into automated IHC workflows, allowing for the accurate identification of both established and novel biomarkers.
In July 2023, Bio-Techne Corporation, a U.S.-based biotechnology and life sciences company, acquired Lunaphore Technologies SA for $170.1 million. This acquisition strengthens Bio-Techne’s position in spatial biology and automated IHC by integrating Lunaphore’s microfluidic staining platforms, enhancing high-throughput tissue analysis and precision research. Lunaphore Technologies SA is a Switzerland-based biotech company specializing in automated immunohistochemistry (IHC) and immunofluorescence (IF) staining instruments.
Major companies operating in the automatic immunohistochemical staining instrument market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Agilent Technologies, Leica Biosystems, Sakura Finetek, Olympus Corporation, Biocare Medical, Celnovte Biotechnology Co. Ltd., BioGenex Laboratories, Diagnostic BioSystems, ADS Biotec, Fuzhou Maixin Biotech Co. Ltd., Shenzhen Dartmon Biotechnology Co. Ltd., Ventana Medical Systems, Dako (Agilent Pathology), Nichirei Biosciences Inc., Abcam plc, Bio-Rad Laboratories, Milestone Medical, Medite GmbH.
North America was the largest region in the automatic immunohistochemical staining instrument market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automatic immunohistochemical staining instrument market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the automatic immunohistochemical staining instrument market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the automatic immunohistochemical staining instrument market by increasing costs of imported precision mechanical components, optical systems, electronic control units, and specialized reagents used in automated stainers. Diagnostic laboratories and hospitals in North America and Europe are most affected due to dependence on imported laboratory equipment, while Asia-Pacific faces pricing pressure on export-oriented instrument manufacturing. These tariffs are raising capital expenditure for pathology labs and slowing equipment replacement cycles. However, they are also encouraging localized manufacturing, regional assembly of diagnostic instruments, and stronger domestic supply chains for critical laboratory technologies.
The automatic immunohistochemical staining instrument market research report is one of a series of new reports that provides automatic immunohistochemical staining instrument market statistics, including automatic immunohistochemical staining instrument industry global market size, regional shares, competitors with a automatic immunohistochemical staining instrument market share, detailed automatic immunohistochemical staining instrument market segments, market trends and opportunities, and any further data you may need to thrive in the automatic immunohistochemical staining instrument industry. This automatic immunohistochemical staining instrument market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
An automatic immunohistochemical staining instrument is a laboratory device designed to automate the staining of tissue samples for detecting specific proteins or antigens. Its main function is to improve the accuracy, consistency, and efficiency of immunohistochemistry (IHC) tests, which are vital for diagnosing diseases such as cancer by visualizing molecular markers in tissue sections.
The main product types include fully automated stainers, semi-automated stainers, and manual stainers. Fully automated stainers are advanced instruments that perform immunohistochemical or histological staining with minimal human input. The technologies used include slide staining, tissue staining, and fluorescent staining. Consumables involved in the process include antibodies, staining kits, slides, and coverslips. Applications cover oncology, cardiovascular diseases, neurological disorders, and infectious diseases. Key end-users include hospitals, diagnostic laboratories, academic institutions, and research laboratories.
The automatic immunohistochemical staining instrument market consists of sales of slide holders, reagent dispensers, detection systems, and associated consumables such as antibodies, detection kits, and chromogens used in the immunohistochemical staining process. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The automatic immunohistochemical staining instrument market size is expected to see strong growth in the next few years. It will grow to $1.83 billion in 2030 at a compound annual growth rate (CAGR) of 7%. The growth in the forecast period can be attributed to increasing adoption of precision oncology diagnostics, growing investments in digital pathology platforms, rising demand for laboratory automation, expansion of companion diagnostics development, increasing focus on personalized medicine approaches. Major trends in the forecast period include increasing adoption of fully automated ihc staining systems, rising demand for high-throughput diagnostic workflows, growing integration of digital pathology compatibility, expansion of standardized and reproducible staining protocols, enhanced focus on workflow efficiency in laboratories.
The increasing prevalence of chronic diseases is expected to drive the growth of the automatic immunohistochemical staining instrument market. Chronic diseases refer to long-term medical conditions that typically progress gradually and require continuous management. These include diabetes, heart disease, hypertension, arthritis, chronic respiratory diseases, cancer, and obesity. The rise in chronic diseases is linked to lifestyle changes, poor diet, and insufficient physical activity, all contributing to long-term health complications. Automatic immunohistochemical staining instruments improve diagnostic capabilities by offering precise and efficient tissue analysis, making them crucial for detecting chronic diseases. These instruments reduce manual labor with fast, automated staining processes, improving diagnostic accuracy and enabling earlier disease detection. For example, in June 2024, the National Health Service (NHS) in the UK reported that 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, an 18% increase from 3,065,825 cases in 2022. Therefore, the growing prevalence of chronic diseases is driving the expansion of the automatic immunohistochemical staining instrument market.
Companies in the automatic immunohistochemical staining instrument market are focusing on developing innovative solutions, such as antibody alternative reagents, to enhance the accuracy, efficiency, and versatility of tissue analysis while reducing costs and improving reproducibility. An antibody alternative reagent is a non-antibody molecule, such as an aptamer, affirmer, or antibody mimetic, that can specifically bind to target antigens and be used instead of traditional antibodies in research, diagnostic, or therapeutic applications. For example, in March 2023, Aptamer Group plc, a U.K.-based biotechnology company, launched Optimer-Fc, a new reagent solution for automated immunohistochemistry (IHC) workflows. Optimer-Fc offers an innovative antibody alternative for immunohistochemistry, expanding target detection capabilities and enhancing assay selectivity. It integrates seamlessly into automated IHC workflows, allowing for the accurate identification of both established and novel biomarkers.
In July 2023, Bio-Techne Corporation, a U.S.-based biotechnology and life sciences company, acquired Lunaphore Technologies SA for $170.1 million. This acquisition strengthens Bio-Techne’s position in spatial biology and automated IHC by integrating Lunaphore’s microfluidic staining platforms, enhancing high-throughput tissue analysis and precision research. Lunaphore Technologies SA is a Switzerland-based biotech company specializing in automated immunohistochemistry (IHC) and immunofluorescence (IF) staining instruments.
Major companies operating in the automatic immunohistochemical staining instrument market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Agilent Technologies, Leica Biosystems, Sakura Finetek, Olympus Corporation, Biocare Medical, Celnovte Biotechnology Co. Ltd., BioGenex Laboratories, Diagnostic BioSystems, ADS Biotec, Fuzhou Maixin Biotech Co. Ltd., Shenzhen Dartmon Biotechnology Co. Ltd., Ventana Medical Systems, Dako (Agilent Pathology), Nichirei Biosciences Inc., Abcam plc, Bio-Rad Laboratories, Milestone Medical, Medite GmbH.
North America was the largest region in the automatic immunohistochemical staining instrument market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automatic immunohistochemical staining instrument market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the automatic immunohistochemical staining instrument market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the automatic immunohistochemical staining instrument market by increasing costs of imported precision mechanical components, optical systems, electronic control units, and specialized reagents used in automated stainers. Diagnostic laboratories and hospitals in North America and Europe are most affected due to dependence on imported laboratory equipment, while Asia-Pacific faces pricing pressure on export-oriented instrument manufacturing. These tariffs are raising capital expenditure for pathology labs and slowing equipment replacement cycles. However, they are also encouraging localized manufacturing, regional assembly of diagnostic instruments, and stronger domestic supply chains for critical laboratory technologies.
The automatic immunohistochemical staining instrument market research report is one of a series of new reports that provides automatic immunohistochemical staining instrument market statistics, including automatic immunohistochemical staining instrument industry global market size, regional shares, competitors with a automatic immunohistochemical staining instrument market share, detailed automatic immunohistochemical staining instrument market segments, market trends and opportunities, and any further data you may need to thrive in the automatic immunohistochemical staining instrument industry. This automatic immunohistochemical staining instrument market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
An automatic immunohistochemical staining instrument is a laboratory device designed to automate the staining of tissue samples for detecting specific proteins or antigens. Its main function is to improve the accuracy, consistency, and efficiency of immunohistochemistry (IHC) tests, which are vital for diagnosing diseases such as cancer by visualizing molecular markers in tissue sections.
The main product types include fully automated stainers, semi-automated stainers, and manual stainers. Fully automated stainers are advanced instruments that perform immunohistochemical or histological staining with minimal human input. The technologies used include slide staining, tissue staining, and fluorescent staining. Consumables involved in the process include antibodies, staining kits, slides, and coverslips. Applications cover oncology, cardiovascular diseases, neurological disorders, and infectious diseases. Key end-users include hospitals, diagnostic laboratories, academic institutions, and research laboratories.
The automatic immunohistochemical staining instrument market consists of sales of slide holders, reagent dispensers, detection systems, and associated consumables such as antibodies, detection kits, and chromogens used in the immunohistochemical staining process. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Automatic Immunohistochemical Staining Instrument Market Characteristics
3. Automatic Immunohistochemical Staining Instrument Market Supply Chain Analysis
4. Global Automatic Immunohistochemical Staining Instrument Market Trends and Strategies
5. Automatic Immunohistochemical Staining Instrument Market Analysis of End Use Industries
7. Global Automatic Immunohistochemical Staining Instrument Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Automatic Immunohistochemical Staining Instrument Total Addressable Market (TAM) Analysis for the Market
9. Automatic Immunohistochemical Staining Instrument Market Segmentation
10. Automatic Immunohistochemical Staining Instrument Market Regional and Country Analysis
11. Asia-Pacific Automatic Immunohistochemical Staining Instrument Market
12. China Automatic Immunohistochemical Staining Instrument Market
13. India Automatic Immunohistochemical Staining Instrument Market
14. Japan Automatic Immunohistochemical Staining Instrument Market
15. Australia Automatic Immunohistochemical Staining Instrument Market
16. Indonesia Automatic Immunohistochemical Staining Instrument Market
17. South Korea Automatic Immunohistochemical Staining Instrument Market
18. Taiwan Automatic Immunohistochemical Staining Instrument Market
19. South East Asia Automatic Immunohistochemical Staining Instrument Market
20. Western Europe Automatic Immunohistochemical Staining Instrument Market
21. UK Automatic Immunohistochemical Staining Instrument Market
22. Germany Automatic Immunohistochemical Staining Instrument Market
23. France Automatic Immunohistochemical Staining Instrument Market
24. Italy Automatic Immunohistochemical Staining Instrument Market
25. Spain Automatic Immunohistochemical Staining Instrument Market
26. Eastern Europe Automatic Immunohistochemical Staining Instrument Market
27. Russia Automatic Immunohistochemical Staining Instrument Market
28. North America Automatic Immunohistochemical Staining Instrument Market
29. USA Automatic Immunohistochemical Staining Instrument Market
30. Canada Automatic Immunohistochemical Staining Instrument Market
31. South America Automatic Immunohistochemical Staining Instrument Market
32. Brazil Automatic Immunohistochemical Staining Instrument Market
33. Middle East Automatic Immunohistochemical Staining Instrument Market
34. Africa Automatic Immunohistochemical Staining Instrument Market
36. Automatic Immunohistochemical Staining Instrument Market Competitive Landscape and Company Profiles
37. Automatic Immunohistochemical Staining Instrument Market Other Major and Innovative Companies
40. Automatic Immunohistochemical Staining Instrument Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Automatic Immunohistochemical Staining Instrument Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses automatic immunohistochemical staining instrument market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for automatic immunohistochemical staining instrument? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The automatic immunohistochemical staining instrument market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Fully Automated Stainers; Semi-Automated Stainers; Manual Stainers2) By Technology: Slide Staining; Tissue Staining; Fluorescent Staining
3) By Consumables: Antibodies; Staining Kits; Slides; Coverslips
4) By Application: Oncology; Cardiovascular Diseases; Neurological Disorders; Infectious Diseases
5) By End-User: Hospitals; Diagnostic Laboratories; Academic Institutes; Research Laboratories
Subsegments:
1) By Fully Automated Stainers: Compact Automated Stainers; High-Throughput Stainers; Benchtop Automated Stainers2) By Semi-Automated Stainers: Programmable Stainers; Timer-Based Stainers; Hybrid Stainers
3) By Manual Stainers: Dip-Type Manual Stainers; Rotary Manual Stainers; Handheld Staining Kits
Companies Mentioned: F. Hoffmann-La Roche AG; Thermo Fisher Scientific; Agilent Technologies; Leica Biosystems; Sakura Finetek; Olympus Corporation; Biocare Medical; Celnovte Biotechnology Co. Ltd.; BioGenex Laboratories; Diagnostic BioSystems; ADS Biotec; Fuzhou Maixin Biotech Co. Ltd.; Shenzhen Dartmon Biotechnology Co. Ltd.; Ventana Medical Systems; Dako (Agilent Pathology); Nichirei Biosciences Inc.; Abcam plc; Bio-Rad Laboratories; Milestone Medical; Medite GmbH
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Automatic Immunohistochemical Staining Instrument market report include:- F. Hoffmann-La Roche AG
- Thermo Fisher Scientific
- Agilent Technologies
- Leica Biosystems
- Sakura Finetek
- Olympus Corporation
- Biocare Medical
- Celnovte Biotechnology Co. Ltd.
- BioGenex Laboratories
- Diagnostic BioSystems
- ADS Biotec
- Fuzhou Maixin Biotech Co. Ltd.
- Shenzhen Dartmon Biotechnology Co. Ltd.
- Ventana Medical Systems
- Dako (Agilent Pathology)
- Nichirei Biosciences Inc.
- Abcam plc
- Bio-Rad Laboratories
- Milestone Medical
- Medite GmbH
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.4 Billion |
| Forecasted Market Value ( USD | $ 1.83 Billion |
| Compound Annual Growth Rate | 7.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 20 |
